» Articles » PMID: 39203857

Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence

Abstract

Aging-related disorders pose significant challenges due to their complex interplay of physiological and metabolic factors, including inflammation, oxidative stress, and mitochondrial dysfunction. Curcumin, a natural compound with potent antioxidant and anti-inflammatory properties, has emerged as a promising candidate for mitigating these age-related processes. However, gaps in understanding the precise mechanisms of curcumin's effects and the optimal dosages for different conditions necessitate further investigation. This systematic review synthesizes current evidence on curcumin's potential in addressing age-related disorders, emphasizing its impact on cognitive function, neurodegeneration, and muscle health in older adults. By evaluating the safety, efficacy, and mechanisms of action of curcumin supplementation, this review aims to provide insights into its therapeutic potential for promoting healthy aging. A systematic search across three databases using specific keywords yielded 2256 documents, leading to the selection of 15 clinical trials for synthesis. Here, we highlight the promising potential of curcumin as a multifaceted therapeutic agent in combating age-related disorders. The findings of this review suggest that curcumin could offer a natural and effective approach to enhancing the quality of life of aging individuals. Further research and well-designed clinical trials are essential to validate these findings and optimize the use of curcumin in personalized medicine approaches for age-related conditions.

Citing Articles

Polyphenols, Alkaloids, and Terpenoids Against Neurodegeneration: Evaluating the Neuroprotective Effects of Phytocompounds Through a Comprehensive Review of the Current Evidence.

de Lima E, Fornari Laurindo L, Cavallari Strozze Catharin V, Direito R, Tanaka M, Jasmin Santos German I Metabolites. 2025; 15(2).

PMID: 39997749 PMC: 11857241. DOI: 10.3390/metabo15020124.


Molecular Mechanisms Underlying Neuroinflammation Intervention with Medicinal Plants: A Critical and Narrative Review of the Current Literature.

Barbalho S, Leme Boaro B, da Silva Camarinha Oliveira J, Patocka J, Lamas C, Tanaka M Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861194 PMC: 11768729. DOI: 10.3390/ph18010133.


AdipoRon's Impact on Alzheimer's Disease-A Systematic Review and Meta-Analysis.

Barbalho S, Fornari Laurindo L, de Oliveira Zanuso B, da Silva R, Gallerani Caglioni L, Nunes Junqueira de Moraes V Int J Mol Sci. 2025; 26(2).

PMID: 39859201 PMC: 11765103. DOI: 10.3390/ijms26020484.


From Serendipity to Precision: Integrating AI, Multi-Omics, and Human-Specific Models for Personalized Neuropsychiatric Care.

Tanaka M Biomedicines. 2025; 13(1).

PMID: 39857751 PMC: 11761901. DOI: 10.3390/biomedicines13010167.


Improved topical delivery of curcumin by hydrogels formed by composite carriers integrated with cyclodextrin metal-organic frameworks and cyclodextrin nanosponges.

Li S, Long M, Li J, Zhang Y, Feng N, Zhang Z Int J Pharm X. 2024; 8:100310.

PMID: 39717567 PMC: 11665533. DOI: 10.1016/j.ijpx.2024.100310.


References
1.
Collard R, Boter H, Schoevers R, Oude Voshaar R . Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc. 2012; 60(8):1487-92. DOI: 10.1111/j.1532-5415.2012.04054.x. View

2.
Oliveira A, Pereira R . Amyotrophic lateral sclerosis (ALS): three letters that change the people's life. For ever. Arq Neuropsiquiatr. 2009; 67(3A):750-82. DOI: 10.1590/s0004-282x2009000400040. View

3.
Malhi G, Mann J . Depression. Lancet. 2018; 392(10161):2299-2312. DOI: 10.1016/S0140-6736(18)31948-2. View

4.
Battaglia S, Avenanti A, Vecsei L, Tanaka M . Neural Correlates and Molecular Mechanisms of Memory and Learning. Int J Mol Sci. 2024; 25(5). PMC: 10931689. DOI: 10.3390/ijms25052724. View

5.
Kobayashi H, Ohnishi T, Nakagawa R, Yoshizawa K . The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis. Int J Geriatr Psychiatry. 2015; 31(8):892-904. PMC: 6084309. DOI: 10.1002/gps.4405. View